(Q45034608)

English

Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

1 reference

based on heuristic

inferred from title

author name string

A Martín

1

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

M D Caballero

2

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

J A Pérez-Simón

3

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

N López-Holgado

4

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

M V Mateos

5

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

M C Cañizo

6

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

J F San Miguel

7

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

language of work or name

0 references

publication date

1 October 2004

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Bone Marrow Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

34

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

675-682

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.bmt.1704595

0 references

Benefit of autologous bone marrow transplantation over sequential chemotherapy in poor-risk aggressive non-Hodgkin's lymphoma: updated results of the prospective study LNH87-2. Groupe d'Etude des Lymphomes de l'Adulte.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

Dose intensification with autologous bone-marrow transplantation in relapsed and resistant Hodgkin's disease: results of a BNLI randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

Long-term follow-up in patients treated with Mini-BEAM as salvage therapy for relapsed or refractory Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

Autologous stem-cell transplantation for Hodgkin's disease: results and prognostic factors in 494 patients from the Grupo Español de Linfomas/Transplante Autólogo de Médula Osea Spanish Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

High-dose chemotherapy and autologous hematopoietic stem-cell transplantation for aggressive non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

High-dose therapy improves progression-free survival and survival in relapsed follicular non-Hodgkin's lymphoma: results from the randomized European CUP trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

Effect of cumulative etoposide doses on the outcome of autologous peripheral-blood progenitor-cell transplantation for lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

High-dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

Treatment-related myelodysplasia and acute leukemia in non-Hodgkin's lymphoma patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

Treatment of patients with relapsed and resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, and cyclophosphamide and autologous bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

21 January 2018

One hundred autotransplants for relapsed or refractory Hodgkin's disease and lymphoma: value of pretransplant disease status for predicting outcome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

High-dose therapy and autologous stem-cell transplantation for adult patients with Hodgkin's disease who do not enter remission after induction chemotherapy: results in 175 patients reported to the European Group for Blood and Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of primary progressive Hodgkin's and aggressive non-Hodgkin's lymphoma: is there a chance for cure?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

BEAM chemotherapy followed by autologous stem cell support in lymphoma patients: analysis of efficacy, toxicity and prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclophosphamide, carmustine, and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma: a dose-finding study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

Busulfan, cyclophosphamide, and melphalan conditioning for autologous bone marrow transplantation in hematologic malignancy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

Dose intensification of etoposide in the BEAM ABMT protocol for malignant lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term results of blood and marrow transplantation for Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparative regimens--a Southwest Oncology Group trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1704595

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.BMT.1704595

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45034608&oldid=2063504076"